<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d1 20130915//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id><journal-id journal-id-type="publisher-id">acn3</journal-id><journal-title-group><journal-title>Annals of Clinical and Translational Neurology</journal-title></journal-title-group><issn pub-type="ppub">2328-9503</issn><issn pub-type="epub">2328-9503</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4284131</article-id><article-id pub-id-type="doi">10.1002/acn3.140</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communications</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Laing distal myopathy pathologically resembling inclusion body myositis </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roda</surname><given-names>Ricardo H</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schindler</surname><given-names>Alice B</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Blackstone</surname><given-names>Craig</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mammen</surname><given-names>Andrew L</given-names></name><xref ref-type="aff" rid="au4">4</xref><xref ref-type="aff" rid="au5">5</xref><xref ref-type="aff" rid="au6">6</xref></contrib><contrib contrib-type="author"><name><surname>Corse</surname><given-names>Andrea M</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name><surname>Lloyd</surname><given-names>Thomas E</given-names></name><xref ref-type="aff" rid="au4">4</xref><xref ref-type="aff" rid="au7">7</xref></contrib><aff id="au1"><label>1</label><institution>Neuromuscular Disorders and Neurogenetics Divisions, Department of Neurology, New York University Langone Medical Center</institution><addr-line>New York, New York</addr-line></aff><aff id="au2"><label>2</label><institution>Cell Biology Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution><addr-line>Bethesda, Maryland</addr-line></aff><aff id="au3"><label>3</label><institution>Hereditary Neurological Diseases Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution><addr-line>Bethesda, Maryland</addr-line></aff><aff id="au4"><label>4</label><institution>Department of Neurology, Johns Hopkins University School of Medicine</institution><addr-line>Baltimore, Maryland</addr-line></aff><aff id="au5"><label>5</label><institution>Department of Medicine, Johns Hopkins University School of Medicine</institution><addr-line>Baltimore, Maryland</addr-line></aff><aff id="au6"><label>6</label><institution>Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health</institution><addr-line>Bethesda, Maryland</addr-line></aff><aff id="au7"><label>7</label><institution>Department of Neuroscience, Johns Hopkins University School of Medicine</institution><addr-line>Baltimore, Maryland</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Ricardo H. Roda, Department of Neurology, New York University, Ambulatory Care Center, 240 East 38th street New York, NY 10016. Tel: (212) 263-7744; Fax: (212) 263-7721; E-mail: <email>ricardo.roda@nyumc.org</email></corresp><fn><p><text><SENT sid="1" pm="."><plain>Funding Information R. H. </plain></SENT>
<SENT sid="3" pm="."><plain>R., A. S., and C. B. were supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health. </plain></SENT>
<SENT sid="6" pm="."><plain>A. </plain></SENT>
<SENT sid="7" pm="."><plain>M. was supported by National Institutes of Health grant K08-AR054783. </plain></SENT>
<SENT sid="8" pm="."><plain>A. </plain></SENT>
<SENT sid="9" pm="."><plain>C. was supported by National Institutes of Health grant R01AR44684. </plain></SENT>
<SENT sid="10" pm="."><plain>T. </plain></SENT>
<SENT sid="11" pm="."><plain>L. was supported by National Institutes of Health Grant R01NS082563. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2014</year></pub-date><volume>1</volume><issue>12</issue><fpage>1053</fpage><lpage>1058</lpage><history><date date-type="received"><day>21</day><month>7</month><year>2014</year></date><date date-type="rev-recd"><day>13</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>14</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 The Authors. <italic>Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals, Inc on behalf of American Neurological Association.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="12" pm="."><plain>Mutations in MYH7 cause autosomal dominant Laing distal myopathy. </plain></SENT>
<SENT sid="13" pm="."><plain>We present a family with a previously reported deletion (c.5186_5188delAGA, p.K1729del). </plain></SENT>
<SENT sid="14" pm="."><plain>Muscle pathology in one family member was characterized by an inflammatory myopathy with rimmed vacuoles, increased MHC Class I expression, and perivascular and endomysial muscle inflammation comprising CD3+, CD4+, CD8+, and CD68+ inflammatory cells. </plain></SENT>
<SENT sid="15" pm="."><plain>Interestingly, this biopsy specimen contained TDP-43, p62, and SMI-31-positive protein aggregates typical of inclusion body myositis. </plain></SENT>
<SENT sid="16" pm="."><plain>These findings should alert physicians to the possibility that patients with MYH7 mutations may have muscle biopsies showing pathologic findings similar to inclusion body myositis. </plain></SENT>
</text></SecTag></p></abstract></article-meta></front><body><SecTag type="INTRO"><sec><title><text><SENT sid="17" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="18" pm="."><plain>The inherited distal myopathies are a group of genetically heterogeneous muscle disorders characterized by weakness of the distal muscles of the arms and legs. </plain></SENT>
<SENT sid="19" pm="."><plain>They are caused by defects in several genes including TTN, DYSF, GNE, LDB3, and MYH7.1MYH7 (slow/β-cardiac myosin heavy chain 7) is expressed in both skeletal muscle and cardiac muscle,2 and mutations can give rise to a familial hypertrophic or dilated cardiomyopathy3 as well as several skeletal muscle disorders: Laing distal myopathy (MPD1; MIM# 160500), scapuloperoneal myopathy (MIM# 181430), and myosin storage myopathy (MSM)/hyaline body myopathy (MIM# 608358). </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>Laing distal myopathy4–7 presents clinically with weakness and atrophy of the forearm finger extensors and the anterior compartment muscles of the legs.1 Only within the last decade, MYH7 has been identified as a gene causing distal skeletal myopathy.6 Although clinical findings have been fairly uniform, biopsy findings have proven to be more varied. </plain></SENT>
<SENT sid="21" pm="."><plain>Observed features include type 1 fiber atrophy, myofiber degeneration with regeneration, endomysial fibrosis, and fatty replacement. </plain></SENT>
<SENT sid="22" pm="."><plain>In addition, findings suggestive of mitochondrial dysfunction such as ragged red fibers have also been noted. </plain></SENT>
<SENT sid="23" pm="."><plain>Rimmed vacuoles, similar to those seen in inclusion body myositis, are observed rarely.5,8 We present a patient with Laing distal myopathy with endomysial invasion by inflammatory cells on muscle biopsy and positive staining for markers associated with inclusion body myositis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CASE"><sec><title><text><SENT sid="24" pm="."><plain>Case Report </plain></SENT>
</text></title><p><text><SENT sid="25" pm="."><plain>We examined five members of this family (Fig.1A), four from generation III (III.7, III.9, III.13, III.15) and one from generation IV (IV.15). </plain></SENT>
<SENT sid="26" pm="."><plain>All subjects provided informed consent to participate in this study under a clinical research protocol approved by the NIH Combined Neuroscience Institutional Review Board. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="fig01" position="float"><label>Figure 1</label><caption><p><text><SENT sid="27" pm="."><plain>Identification of MYH7 mutation and clinical characteristics. </plain></SENT>
<SENT sid="28" pm="."><plain>(A) Pedigree of the reported family. </plain></SENT>
<SENT sid="29" pm="."><plain>The proband (III.15), indicated by the arrow, carries the c.5186_5188delAGA (p.K1729del) mutation. </plain></SENT>
<SENT sid="30" pm="."><plain>Subjects III.7, III.9, III.13, and IV.15 all tested positive for the mutation. </plain></SENT>
<SENT sid="31" pm="."><plain>Filled symbols indicate affected members of the family, arrowheads point to those tested for the mutation. </plain></SENT>
<SENT sid="32" pm="."><plain>(B) T1-weighted MRI of the upper thighs of index patient III.15 shows atrophy and fatty replacement of quadriceps and rectus femoris with sparing of the abductors, hamstring, and right vastus intermedius and vastus medialis. </plain></SENT>
<SENT sid="33" pm="."><plain>An arrow points to an area of atrophy and fatty replacement. </plain></SENT>
<SENT sid="34" pm="."><plain>(C) Selected physical findings from subjects with MYH7 mutation. </plain></SENT>
<SENT sid="35" pm="."><plain>Clockwise from top left: III.13 has significant calf hypertrophy; III.9 displays anterior compartment atrophy; quadriceps atrophy is also observed in III.7; III.9 showing limited wrist extension due to weakness of the extensor compartment of the arm. </plain></SENT>
<SENT sid="36" pm="."><plain>The “hanging big toe sign” was observed in all patients; in this image, the foot of IV.15 is shown. </plain></SENT>
</text></p></caption><graphic xlink:href="acn30001-1053-f1"/></fig></SecTag><p><text><SENT sid="37" pm="."><plain>The family traces their roots to German immigrants to the United States. </plain></SENT>
<SENT sid="38" pm="."><plain>The proband, III.15, is a 52-year-old male who first noted difficulty running as a teenager. </plain></SENT>
<SENT sid="39" pm="."><plain>This progressed in his early twenties, at which point he could not rise from a squat. </plain></SENT>
<SENT sid="40" pm="."><plain>In his early thirties he noticed atrophy of his quadriceps, and in his late forties he required a cane to ambulate. </plain></SENT>
<SENT sid="41" pm="."><plain>He came to our attention at the age of 51 years. </plain></SENT>
<SENT sid="42" pm="."><plain>On neurological examination, he showed weakness in his arms on wrist flexion and extension as well as finger flexion and extension, while in the lower extremities he exhibited hip flexion, knee extension, and severe ankle dorsiflexion and large toe extensor weakness. </plain></SENT>
<SENT sid="43" pm="."><plain>He had atrophy of the quadriceps and anterior compartment of the leg. </plain></SENT>
<SENT sid="44" pm="."><plain>His quadriceps atrophy and wrist and finger flexion weakness were reminiscent of sporadic IBM (sIBM). </plain></SENT>
<SENT sid="45" pm="."><plain>Muscle MRI of the lower extremities showed asymmetric atrophy and fatty replacement of the vastus intermedius and vastus medialis (Fig.1B). </plain></SENT>
<SENT sid="46" pm="."><plain>This type of asymmetry is typical of sIBM.9 Particularly worrisome to the patient was that his rate of worsening had significantly increased over the past several years, and he had new onset of hand weakness over the past few years. </plain></SENT>
<SENT sid="47" pm="."><plain>Interestingly, his family tree (Fig.1A) suggested that other family members might also be affected with muscle disease. </plain></SENT>
</text></p><p><text><SENT sid="48" pm="."><plain>To further characterize the phenotype in this family, additional family members underwent neurological examination at our institution (Fig.1C) (summarized in Table1). </plain></SENT>
<SENT sid="49" pm="."><plain>Subject III.9 is a 62-year-old man who first developed difficulty walking at the age of 10 years. </plain></SENT>
<SENT sid="50" pm="."><plain>He was able to play baseball in high school but was not a fast runner. </plain></SENT>
<SENT sid="51" pm="."><plain>He noted in his early thirties that his gait was stable when wearing boots that provided ankle support. </plain></SENT>
<SENT sid="52" pm="."><plain>Exam showed wrist drop and finger extension weakness (Fig.1C). </plain></SENT>
<SENT sid="53" pm="."><plain>He had a left gastrocnemius muscle biopsy, for which we only have a report, which notes that there was a small number of necrotic but no regenerating fibers. </plain></SENT>
<SENT sid="54" pm="."><plain>There was no inflammation and no vacuoles. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p><text><SENT sid="55" pm="."><plain>Clinical features </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>III.7 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>III.9 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>III.13 </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>III.15* </plain></SENT>
</text></th><th align="left" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>IV.15 </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>Age at examination </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>62 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>51 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>28 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>Age of onset of symptoms </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>Early teens </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>Early teens </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>Late thirties </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>Mid teens </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>None yet </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>Flat smile </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>“Hanging Big Toe” sign </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>Quadriceps atrophy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>+++ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>+++ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>+ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>+++ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>Tibialis anterior atrophy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>++ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>+ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>+ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>++ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>+ </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>Able to stand on heels </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>Calf Hypertrophy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>Yes, asymm </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>Yes, asymm </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>Weakness of wrist and finger extensors </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>Yes, asymm </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>Yes, asymm </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>Weakness of wrist and finger flexors </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>Scapular winging </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>High arched palate </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>No </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>CK, U/L (nl 52–386) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>166 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>161 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>172 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>57 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>Sensory exam </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>Reduced vibration </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>Normal </plain></SENT>
</text></td></tr><tr><td align="left" colspan="6" rowspan="1"><text><SENT sid="145" pm="."><plain>Cardiac evaluation </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain> EKG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>Normal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain> Echocardiogram </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>EF 50% </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="158" pm="."><plain>Atrophy was rated as mild (+), moderate (++) and severe (+++). </plain></SENT>
<SENT sid="159" pm="."><plain>Asymm, asymmetric; ND, not done. </plain></SENT>
</text></p></fn><fn id="tf1-1"><label>*</label><p><text><SENT sid="160" pm="."><plain>Index case. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="161" pm="."><plain>Subject III.13 is a 54-year-old man who initially noted frequent falls while playing sports in his late thirties. </plain></SENT>
<SENT sid="162" pm="."><plain>His exam showed quadriceps and tibialis anterior atrophy, toe dorsiflexion weakness, and calf hypertrophy (Fig.1C). </plain></SENT>
</text></p><p><text><SENT sid="163" pm="."><plain>IV.15 is a 28-year-old man who was asymptomatic but noted to have mild weakness of toe dorsiflexion on exam (Fig.1C). </plain></SENT>
</text></p><p><text><SENT sid="164" pm="."><plain>III.7 is a 63-year-old man who developed difficulty walking in his early teenage years. </plain></SENT>
<SENT sid="165" pm="."><plain>Gait instability slowly progressed until he started to fall frequently in his fifties. </plain></SENT>
<SENT sid="166" pm="."><plain>On exam he had mild facial weakness, mild-to-moderate proximal lower extremity weakness and atrophy, (Fig.1C) and weakness of ankle dorsiflexion and toe extension. </plain></SENT>
<SENT sid="167" pm="."><plain>All family members with the exception of IV.15 had involvement of the distal upper limb (Table1). </plain></SENT>
</text></p><p><text><SENT sid="168" pm="."><plain>Given the mixed clinical features at presentation of our index patient, we decided to proceed with muscle tissue evaluation before genetic testing. </plain></SENT>
<SENT sid="169" pm="."><plain>A first biopsy of the right thigh of the index patient done several years before was only moderately useful, showing extensive fatty replacement, endomysial fibrosis, fiber size variation, and endomysial perivascular inflammation with rare vacuolated fibers (Fig.2A–C). </plain></SENT>
<SENT sid="170" pm="."><plain>We performed an additional muscle biopsy of the left biceps and performed immunostaining for inflammatory cells and proteinaceous aggregates (Figs.2, 3). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="fig02" position="float"><label>Figure 2</label><caption><p><text><SENT sid="171" pm="."><plain>Histological and immunological analysis of muscle specimens. </plain></SENT>
<SENT sid="172" pm="."><plain>(A) Frozen H&amp;E and (B and C) Gomori trichrome stains from the initial biopsy of index case. </plain></SENT>
<SENT sid="173" pm="."><plain>Follow-up biopsy years later. </plain></SENT>
<SENT sid="174" pm="."><plain>(D and E) H&amp;E staining of frozen and paraffin sections and (F) CD3 stain show normal fibers undergoing invasion by mononuclear cells. </plain></SENT>
<SENT sid="175" pm="."><plain>(G) Vacuoles which are blue-rimmed on H&amp;E and red-rimmed on Gomori trichrome are also seen. </plain></SENT>
<SENT sid="176" pm="."><plain>(H) H&amp;E stain of frozen sections shows an area of perivascular inflammation, and (I) acid phosphatase staining is increased in fibers undergoing myophagocytosis. </plain></SENT>
<SENT sid="177" pm="."><plain>(J) Several blue COX-negative fibers are visualized. </plain></SENT>
<SENT sid="178" pm="."><plain>Scale bar, 100 μm, otherwise magnification is shown on the image label. </plain></SENT>
</text></p></caption><graphic xlink:href="acn30001-1053-f2"/></fig></SecTag><SecTag type="FIG"><fig id="fig03" position="float"><label>Figure 3</label><caption><p><text><SENT sid="179" pm="."><plain>Immunohistochemical analysis of the specimen. </plain></SENT>
<SENT sid="180" pm="."><plain>(A) Increased MHC-I expression, compare to (B) control, and T-cell predominant lymphocytic infiltrates (C) CD4+ and (D) CD8+. </plain></SENT>
<SENT sid="181" pm="."><plain>Perivascular infiltrates are also seen, which stain with the markers (E) MHC-I and (F) CD68+. </plain></SENT>
<SENT sid="182" pm="."><plain>Immunostaining indicates the presence of markers for IBM including (G) TDP43, (H) SMI-31, and (I) p62. </plain></SENT>
<SENT sid="183" pm="."><plain>Scale bar, 100 μm; otherwise, magnification is shown on image labels. </plain></SENT>
</text></p></caption><graphic xlink:href="acn30001-1053-f3"/></fig></SecTag><p><text><SENT sid="184" pm="."><plain>On frozen H&amp;E stains, there was fiber size variability with rounded and polygonal myofiber atrophy, rare hypertrophied fibers, and occasional angular atrophic fibers (Fig.2D). </plain></SENT>
<SENT sid="185" pm="."><plain>Most importantly, there were also many areas of primary endomysial inflammation (Fig.2D–F and Fig. </plain></SENT>
<SENT sid="186" pm="."><plain>S1A–C), with chronic mononuclear inflammatory cells surrounding and invading nonnecrotic fibers as well as perivascular chronic inflammation seen on frozen (Fig.2H and Fig. </plain></SENT>
<SENT sid="187" pm="."><plain>S1B) and paraffin sections. </plain></SENT>
<SENT sid="188" pm="."><plain>Many fibers contained small to medium-sized vacuoles, both subsarcolemmal and sarcoplasmic in location (Fig.2G and Fig. </plain></SENT>
<SENT sid="189" pm="."><plain>S1E and F). </plain></SENT>
<SENT sid="190" pm="."><plain>These vacuoles were blue-rimmed on H&amp;E staining and red rimmed on Gomori trichrome staining. </plain></SENT>
<SENT sid="191" pm="."><plain>Many of the vacuoles were also acid phosphatase positive. </plain></SENT>
</text></p><p><text><SENT sid="192" pm="."><plain>In addition, we noted myofiber degeneration and necrosis with occasional regeneration. </plain></SENT>
<SENT sid="193" pm="."><plain>There were many fibers undergoing myophagocytosis, and acid phosphatase staining was increased in degenerating and necrotic fibers and in the areas of myophagocytosis (Fig.2I). </plain></SENT>
<SENT sid="194" pm="."><plain>There were many COX-negative fibers, some of which were SDH dark (Fig.2J). </plain></SENT>
<SENT sid="195" pm="."><plain>Ragged red fibers were also seen. </plain></SENT>
<SENT sid="196" pm="."><plain>Many fibers also showed increased subsarcolemmal NADH staining (not shown). </plain></SENT>
</text></p><p><text><SENT sid="197" pm="."><plain>Immunostaining demonstrated markedly increased MHC Class I staining in nonnecrotic myofibers (Fig.3A), and also in perimysial regions (Fig.3E). </plain></SENT>
<SENT sid="198" pm="."><plain>There were many scattered CD4+ (Fig.3C), CD8+ (Fig.3D), and CD68+ cells (Fig.3F) in the endomysium and invading degenerating fibers as well as in the perivascular infiltrates. </plain></SENT>
<SENT sid="199" pm="."><plain>CD20+ cells were rare. </plain></SENT>
</text></p><p><text><SENT sid="200" pm="."><plain>Significantly, many muscle fibers were positive for proteinaceous inclusions commonly seen in sporadic inclus-ion body myositis (s-IBM): TDP-43, p62, and SMI-31 (Fig.3G–I). </plain></SENT>
<SENT sid="201" pm="."><plain>We are not aware of cases in which these antibodies have been tested in cases of Laing distal myopathy. </plain></SENT>
<SENT sid="202" pm="."><plain>Testing of the proband revealed a c.5186_5188delAGA (p.K1729del) deletion in exon 36 of MYH7. </plain></SENT>
<SENT sid="203" pm="."><plain>Additional affected family members also tested positive for the same mutation. </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="204" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="205" pm="."><plain>Mutations in MYH7 cause Laing distal myopathy (MPD1), myosin storage/hyaline body myopathy, scapuloperoneal myopathy, and familial hypertrophic or dilated cardiomyopathy. </plain></SENT>
<SENT sid="206" pm="."><plain>In this report, we present a family of German ancestry with a c.5186_5188delAGA (p.K1729del) deletion in exon 36 of MYH7. </plain></SENT>
<SENT sid="207" pm="."><plain>A similar mutation resulting in the same amino acid deletion is also associated with a skeletal myopathy reported previously in an American family of Italian descent and in a family from Spain.6,10–12 </plain></SENT>
</text></p><p><text><SENT sid="208" pm="."><plain>Onset of symptoms in our kindred was in the teenage years (Table1), with two exceptions. </plain></SENT>
<SENT sid="209" pm="."><plain>Subject III.9 developed symptoms in his thirties, and IV.15 denied symptoms despite having toe extensor weakness on exam. </plain></SENT>
<SENT sid="210" pm="."><plain>The distribution of weakness in the patients we examined was in toe and ankle dorsiflexion initially, then progressed to involve finger extensors, in agreement with other reports typical of patients with Laing distal myopathy. </plain></SENT>
<SENT sid="211" pm="."><plain>Our index patient, however, had distinct finger flexor weakness. </plain></SENT>
</text></p><p><text><SENT sid="212" pm="."><plain>The biopsy findings in Laing early onset distal myopathy are pleiotropic. </plain></SENT>
<SENT sid="213" pm="."><plain>Both Muelas et al. and Lamont et al. have summarized many of the reported findings.10,13 Myofiber size variability, degenerating and regenerating fibers, endomysial fibrosis with fatty replacement, type 1 fiber atrophy, ragged red fibers, and sarcoplasmic inclusions have all been observed. </plain></SENT>
<SENT sid="214" pm="."><plain>Cores and minicores have been reported as well in patients with mutations in MYH7.10,13 </plain></SENT>
</text></p><p><text><SENT sid="215" pm="."><plain>Inflammation is seen in other muscular dystrophies including the dystrophinopathies, dysferlinopathies, and facioscapulohumeral muscular dystrophy among others. </plain></SENT>
<SENT sid="216" pm="."><plain>A single report has shown rare inflammation mostly surrounding and within degenerating fibers in a patient with a MYH7 mutation.14 The nature of the infiltrate was noted to be mostly CD4 and CD68 positive, with only faint expression of MHC-I. </plain></SENT>
<SENT sid="217" pm="."><plain>In the case presented here, the presence of primary inflammation in combination with red-rimmed vacuoles and positive staining for proteinaceous aggregates has not been reported in Laing myopathy patients. </plain></SENT>
</text></p><p><text><SENT sid="218" pm="."><plain>The presence of primary inflammation and red-rimmed vacuoles is a hallmark of inclusion body myositis. </plain></SENT>
<SENT sid="219" pm="."><plain>In the index patient, we have demonstrated T-cell predominant inflammatory infiltrates surrounding and invading nonnecrotic fibers and increased MHC-I staining. </plain></SENT>
<SENT sid="220" pm="."><plain>We have also observed red-rimmed vacuoles and positive staining for TDP-43, p62, and phospho-Tau (SMI-31)-positive protein aggregates. </plain></SENT>
<SENT sid="221" pm="."><plain>A recent study by Brady et al. found that in biopsies in which vacuoles were present, the combination of a specific pattern of p62 staining, and increased MHC-I staining yielded a sensitivity of 93% and specificity of 100% for IBM, demonstrating the utility of this particular stain as a diagnostic marker.15 This case, though, demonstrates that some inherited myopathies may also yield similar findings on muscle biopsy and emphasizes the importance of the clinical exam. </plain></SENT>
</text></p><p><text><SENT sid="222" pm="."><plain>Genetic testing provided the definitive diagnosis, confirming the pathogenic mutation in MYH7. </plain></SENT>
<SENT sid="223" pm="."><plain>The mixed clinical presentation as well as the pathology findings raises the remote possibility that the index case suffers from both Laing distal myopathy and sporadic IBM. </plain></SENT>
<SENT sid="224" pm="."><plain>The co-occurrence of an inflammatory myopathy with an inherited myopathy has been previously reported16 and we have seen other sporadic IBM patients with inherited neuromuscular diseases, including FSHD (pers. comm.). </plain></SENT>
<SENT sid="225" pm="."><plain>In order to determine whether our patient had IBM in additional to Laing distal myopathy, further investigations to identify protein aggregates labeled for SMI 31 and p62 in this and other distal myopathies with rimmed vacuoles would be helpful. </plain></SENT>
<SENT sid="226" pm="."><plain>These issues notwithstanding, this case report highlights the need to consider genetic muscle disease in patients with an atypical IBM history and phenotype (in our case, positive family history, weakness onset before the age of 45, and wrist/finger extensor weakness greater than flexor weakness) even in the context of classic IBM pathology. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="227" pm="."><plain>We thank Elizabeth Hartnett for her help with patient scheduling and Noel Carter for assistance with the immunohistochemical stains. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="COMP_INT"><sec><title>Conflict of Interest</title><p>None declared.</p></sec></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="b1"><text><SENT sid="228" pm="."><plain>1UddBDistal myopathies–new genetic entities expand diagnostic challengeNeuromuscul Disord20122251222197426 </plain></SENT>
</text></ref><ref id="b2"><text><SENT sid="229" pm="."><plain>2OldforsAHereditary myosin myopathiesNeuromuscul Disord20071735536717434305 </plain></SENT>
</text></ref><ref id="b3"><text><SENT sid="230" pm="."><plain>3WalshRRutlandCThomasRLoughnaSCardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestationsCardiology2010115496019864899 </plain></SENT>
</text></ref><ref id="b4"><text><SENT sid="231" pm="."><plain>4BohlegaSAbu-AmeroSNWakilSMMutation of the slow myosin heavy chain rod domain underlies hyaline body myopathyNeurology2004621518152115136674 </plain></SENT>
</text></ref><ref id="b5"><text><SENT sid="232" pm="."><plain>5LaingNGLaingBAMeredithCAutosomal dominant distal myopathy: linkage to chromosome 14Am J Hum Genet1995564224277847377 </plain></SENT>
</text></ref><ref id="b6"><text><SENT sid="233" pm="."><plain>6MeredithCHerrmannRParryCMutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early-onset distal myopathy (MPD1)Am J Hum Genet20047570370815322983 </plain></SENT>
</text></ref><ref id="b7"><text><SENT sid="234" pm="."><plain>7TajsharghiHThornellL-ELindbergCMyosin storage myopathy associated with a heterozygous missense mutation in MYH7Ann Neurol20035449450014520662 </plain></SENT>
</text></ref><ref id="b8"><text><SENT sid="235" pm="."><plain>8VoitTKutzPLeubeBAutosomal dominant distal myopathy: further evidence of a chromosome 14 locusNeuromuscul Disord200111111911166161 </plain></SENT>
</text></ref><ref id="b9"><text><SENT sid="236" pm="."><plain>9CoxFMReijnierseMvan RijswijkCSPMagnetic resonance imaging of skeletal muscles in sporadic inclusion body myositisRheumatology (Oxford)2011501153116121288962 </plain></SENT>
</text></ref><ref id="b10"><text><SENT sid="237" pm="."><plain>10MuelasNHackmanPLuqueHMYH7 gene tail mutation causing myopathic profiles beyond Laing distal myopathyNeurology20107573274120733148 </plain></SENT>
</text></ref><ref id="b11"><text><SENT sid="238" pm="."><plain>11HederaPPettyEMBuiMRThe second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysisArch Neurol2003601321132512975303 </plain></SENT>
</text></ref><ref id="b12"><text><SENT sid="239" pm="."><plain>12MuelasNHackmanPLuqueHSpanish MYH7 founder mutation of Italian ancestry causing a large cluster of Laing myopathy patientsClin Genet20128149149421395566 </plain></SENT>
</text></ref><ref id="b13"><text><SENT sid="240" pm="."><plain>13LamontPJUddBMastagliaFLLaing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsyJ Neurol Neurosurg Psychiatry20067720821516103042 </plain></SENT>
</text></ref><ref id="b14"><text><SENT sid="241" pm="."><plain>14TascaGRicciEPenttiläSNew phenotype and pathology features in MYH7-related distal myopathyNeuromuscul Disord20122264064722521714 </plain></SENT>
</text></ref><ref id="b15"><text><SENT sid="242" pm="."><plain>15BradySSquierWSewryCA retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositisBMJ Open20144e004552 </plain></SENT>
</text></ref><ref id="b16"><text><SENT sid="243" pm="."><plain>16ClaeysKGGorodinskayaOHandtSDiagnostic challenge and therapeutic dilemma in necrotizing myopathyNeurology20138193293523921885 </plain></SENT>
</text></ref></ref-list></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material"><title>Supporting Information</title><p>Additional Supporting Information may be found in the online version of this article:</p><supplementary-material content-type="local-data" id="SD1"><caption><p><text><SENT sid="244" pm="."><plain>Figure S1. (A and B) H&amp;E at two magnifications showing endomysial inflammation. </plain></SENT>
<SENT sid="245" pm="."><plain>(C) Congo red stain demonstrates primary inflammation. </plain></SENT>
<SENT sid="246" pm="."><plain>(D) ATPase pH 9.4. </plain></SENT>
<SENT sid="247" pm="."><plain>(E) Gomori trichrome and (F) H&amp;E show additional vacuoles; insert shows a vacuolated fiber from 10× image (white dashed lines). </plain></SENT>
</text></p></caption><media mimetype="application" mime-subtype="tif" xlink:href="acn30001-1053-sd1.tif" xlink:type="simple" id="d35e1277" position="anchor"/></supplementary-material></sec></SecTag></back></article>
